Publisher： Karger
E-ISSN： 1421-9662|132|2|240-243
ISSN： 0001-5792
Source： Acta Haematologica, Vol.132, Iss.2, 2014-05, pp. : 240-243
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This is the case of a 79-year-old man with chronic lymphocytic leukemia who presented with Guillain-Barré syndrome with features overlapping with the Miller Fisher syndrome and Bickerstaff brainstem encephalitis and positive antiganglioside GQ1b antibody about 6 months after treatment with bendamustine and rituximab. His clinical and neurologic condition continued to deteriorate despite sequential treatment with corticosteroids, intravenous immunoglobulin and plasmapheresis, but in the end, he had a complete and durable response to treatment with alemtuzumab.
Related content
Access to resources
Recommend
Unsuccessful Dasatinib Therapy in a Refractory Patient with Chronic Lymphocytic Leukemia
Acta Haematologica, Vol. 124, Iss. 2, 2010-08 ,pp. :